Subscribe to receive information about ongoing or future research studies. In addition, you will receive information about seminars on diabetes, as well as period electronic newsletters.
The UF Diabetes Institute offers many studies encompassing a wide range of disciplines and specialties related to the physiology, pathogenesis and treatment of diabetes, as well as its complications, and translation of new knowledge to the clinic and the community.
These studies are aimed at finding ways to prevent type 1 diabetes. Reserachers are looking for at-risk T1D individuals. Individuals can be screened for T1D risk through TrialNet at UF.
UF researchers are working to delay and ultimately stop the onset of diabetes by evaluating new approaches to prevent or ameliorate the disease in its earliest stage to optimize the potential for successful treatment.
Research studies range from preserving insulin producing cells, to targeted treatment therapies that aim to alter or slow-down the progression of the disease.
- Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients (SUNRISE)
- Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT)
- Lactobacillus Johnsonii Supplementation in Adults With T1D
- Lactobacillus Johnsonii in Children and Adolescents With T1D
- Diabetes Journey: An Adolescent Adherence Barriers Intervention
- Continuous Monitoring and Control of Hypoglycemia (COACH)
- The Environmental Determinants of Diabetes in Youth (TEDDY)
- Type 1 Diabetes TrialNet
- Network for Pancreatic Organ Donors with Diabetes (nPOD) program
- Project Endo Echo grant for Type 1 diabetes